InsiderClue
← All stocks

Axogen, Inc.

AXGN Net selling
CIK 0000805928 #1882 in the set updated 17 Sep 2026
Bought (120 mo)
$2.12M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$88.03M
$1.43M on a plan · $16.17M straight out of an exercise
Sold at will
$70.44M
93 of 148 sales
Net
−$85.92M
−$68.33M against sales at will

By person

35 insiders · 255 transactions
4.0×

Michael Dale holds only 4.0 times base salary in stock. $3.16M of shares against $775.87K in salary for 2025.

Salary from the company's own proxy. The shares are what Michael Dale last reported holding, valued at $49.70, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
EW Healthcare Partners, L.P. entity
10% owner
—
$22.70M (1)
−$22.70M
3,711,111
6.90%
$184.43M
−23.7%
NEELS GUIDO J
Director
$61.10K (1)
$22.74M (2)
−$22.68M
3,457,854
6.43%
$171.84M
−23.5%
Grooms Jamie Mark
Director
—
$9.19M (13)
−$9.19M
19,065
0.0355%
$947.47K
−94.3%
Freitag Gregory Gene
Director
—
$4.15M (15)
−$4.15M
283,498
0.5273%
$14.09M
+429.5%
Began Marc A
EVP & General Counsel
—
$3.88M (3) scheduled
−$3.88M
50,135
0.0933%
$2.49M
—
Burke William P. Mr.
Director
$65.60K (1)
$2.86M (14) scheduled
−$2.80M
14,250
0.0265%
$708.18K
—
Weiler Kathy Johnson
Director
—
$2.78M (6) scheduled
−$2.78M
0
0.0000%
$0.00
—
DALE MICHAEL D
Chief Executive Officer
—
$2.67M (2)
−$2.67M
63,537
0.1182%
$3.16M
—
Zaderej Karen L.
CEO
$1.09M (2)
$3.48M (13)
−$2.39M
1,143,788
2.13%
$56.84M
+469.7%
MARIANI PETER J
EVP & Chief Financial Officer
$25.00K (1)
$2.23M (16) scheduled
−$2.21M
63,603
0.1183%
$3.16M
+1,240%
JOHNSON JOHN
Director
—
$1.91M (6) scheduled
−$1.91M
14,150
0.0263%
$703.21K
—
Wendell Amy McBride
Director
$447.94K (4)
$2.14M (7) scheduled
−$1.69M
107,976
0.2008%
$5.37M
—
TYNDALL JOSEPH A.
Director
—
$1.49M (7) scheduled
−$1.49M
10,650
0.0198%
$529.27K
+321.8%
Donovan Michael Patrick
VP Operations
—
$1.15M (12)
−$1.15M
54,250
0.1009%
$2.70M
—
DeVinney Erick Wayne
Chief Innovation Officer
—
$1.11M (9)
−$1.11M
262,781
0.4888%
$13.06M
+2,322%
Hartley Lindsey Marie
CFO
—
$942.20K (5) scheduled
−$942.20K
65,146
0.1212%
$3.24M
+182.7%
THOMAS PAUL
Director
—
$633.71K (1)
−$633.71K
32,395
0.0603%
$1.61M
—
Hansen David K
VP Finance & Treasurer
—
$452.60K (1)
−$452.60K
25,588
0.0476%
$1.27M
+149.4%
MCCARREY SHAWN F
SVP Sales
—
$434.70K (1)
−$434.70K
82,921
0.1542%
$4.12M
+141.0%
Kemp Jens
Chief Marketing Officer
—
$428.29K (2)
−$428.29K
72,451
0.1348%
$3.60M
+125.6%
Rudelius Robert James
Director
—
$290.57K (1)
−$290.57K
48,183
0.0896%
$2.39M
+107.0%
Blackford Quentin S.
Director
$217.67K (3)
—
+$217.67K
27,335
0.0508%
$1.36M
—
Quackenbush Doris
Sales VP
—
$168.72K (1)
−$168.72K
92,416
0.1719%
$4.59M
−4.0%
Billet Isabelle
Chief Strategy and BD Officer
$85.14K (13)
$11.56K (1)
+$73.58K
25,065
0.0466%
$1.25M
+563.1%
Scopelianos Angelo
Chief R&D Officer
—
$62.94K (4) scheduled
−$62.94K
57,994
0.1079%
$2.88M
+658.9%
Gold Mark Stephen
Director
$52.39K (6)
—
+$52.39K
601,741
1.12%
$29.90M
−5.9%
Levine Alan M
Director
—
$43.21K (1)
−$43.21K
50,893
0.0947%
$2.53M
—
Engels John P
VP
$30.00K (1)
—
+$30.00K
98,425
0.1831%
$4.89M
+4.2%
MARTINEZ MARIA D.
Chief Human Resources Officer
$30.26K (1)
$60.11K (2)
−$29.85K
30,476
0.0567%
$1.51M
—
Leach Kevin
Vice President
$15.00K (1)
—
+$15.00K
2,000
0.0037%
$99.39K
—
Friedman Mark Louis
VP Regulatory Affairs & Policy
—
$11.67K (2)
−$11.67K
24,343
0.0453%
$1.21M
+105.0%
Naor Nir
CFO
—
—
—
260,868
0.4852%
$12.96M
—
Ottinger Bradley
General Counsel and CCO
—
—
—
23,627
0.0439%
$1.17M
+468.2%
Sandberg Eric
Chief Commercial Officer
—
—
—
16,081
0.0299%
$799.18K
—
Gingrich Jon S.
Chief Commercial Officer
—
—
—
4,190
0.0078%
$208.23K
+150.4%

Individual transactions

48
Insider
Date
Role
Action
Shares
Price
Amount
Wendell Amy McBride
11 Aug 2026
Director
Sold after exercise
13,353
$48.42
$646.59K
Began Marc A
10 Aug 2026
EVP & General Counsel
Sold after exercise
67,500
$47.35
$3.20M
Wendell Amy McBride
8 May 2026
Director
Sold after exercise
1,647
$42.60
$70.16K
Hartley Lindsey Marie
7 May 2026
CFO
Sold after exercise
573
$43.67
$25.02K
Hartley Lindsey Marie
7 May 2026
CFO
Sold after exercise
478
$43.67
$20.87K
Weiler Kathy Johnson
7 May 2026
Director
Sold after exercise
16,344
$44.09
$720.62K
JOHNSON JOHN
7 May 2026
Director
Sold after exercise
11,050
$43.26
$477.97K
DeVinney Erick Wayne
16 Mar 2026
Chief Innovation Officer
Sold after exercise
5,221
$32.84
$171.46K
Weiler Kathy Johnson
16 Dec 2025
Director
Sold after exercise
6,580
$29.55
$194.44K
Weiler Kathy Johnson
16 Dec 2025
Director
Sold after exercise
21,825
$29.55
$644.86K
Weiler Kathy Johnson
16 Dec 2025
Director
Sold after exercise
18,248
$29.55
$539.17K
Wendell Amy McBride
16 Dec 2025
Director
Sold after exercise
18,248
$29.31
$534.89K
Wendell Amy McBride
16 Dec 2025
Director
Sold after exercise
20,436
$29.31
$599.02K
Wendell Amy McBride
16 Dec 2025
Director
Sold after exercise
5,000
$29.31
$146.56K
Hartley Lindsey Marie
15 Dec 2025
CFO
Sold after exercise
14,812
$29.86
$442.29K
JOHNSON JOHN
9 Dec 2025
Director
Sold after exercise
13,141
$29.98
$393.99K
JOHNSON JOHN
9 Dec 2025
Director
Sold after exercise
8,545
$29.98
$256.20K
TYNDALL JOSEPH A.
9 Dec 2025
Director
Sold after exercise
10,860
$30.98
$336.41K
TYNDALL JOSEPH A.
9 Dec 2025
Director
Sold after exercise
14,248
$30.98
$441.36K
Hartley Lindsey Marie
8 Dec 2025
CFO
Sold after exercise
2,854
$31.56
$90.07K
Hartley Lindsey Marie
8 Dec 2025
CFO
Sold after exercise
11,533
$31.56
$363.94K
JOHNSON JOHN
8 Dec 2025
Director
Sold after exercise
11,891
$31.22
$371.27K
JOHNSON JOHN
8 Dec 2025
Director
Sold after exercise
11,802
$31.26
$368.93K
Burke William P. Mr.
11 Nov 2025
Director
Sold after exercise
3,591
$24.02
$86.25K
Burke William P. Mr.
10 Nov 2025
Director
Sold after exercise
19,227
$24.01
$461.64K
Burke William P. Mr.
6 Nov 2025
Director
Sold after exercise
5,347
$24.01
$128.37K
Burke William P. Mr.
5 Nov 2025
Director
Sold after exercise
11,431
$24.05
$274.89K
Burke William P. Mr.
30 Oct 2025
Director
Sold after exercise
18,248
$23.00
$419.70K
Burke William P. Mr.
29 Oct 2025
Director
Sold after exercise
19,799
$22.00
$435.58K
Burke William P. Mr.
29 Oct 2025
Director
Sold after exercise
20,436
$19.15
$391.44K
TYNDALL JOSEPH A.
10 Jun 2025
Director
Sold after exercise
26,931
$10.72
$288.70K
TYNDALL JOSEPH A.
22 May 2025
Director
Sold after exercise
7,212
$11.20
$80.77K
TYNDALL JOSEPH A.
22 May 2025
Director
Sold after exercise
12,850
$11.20
$143.92K
Scopelianos Angelo
21 Mar 2024
Chief R&D Officer
Sold after exercise
610
$7.68
$4.68K
Scopelianos Angelo
21 Mar 2024
Chief R&D Officer
Sold after exercise
1,020
$7.68
$7.83K
Scopelianos Angelo
21 Mar 2024
Chief R&D Officer
Sold after exercise
5,251
$7.68
$40.33K
Freitag Gregory Gene
1 Jun 2023
Director
Sold after exercise
29,480
$8.74
$257.66K
Freitag Gregory Gene
1 Jun 2023
Director
Sold after exercise
12,500
$8.65
$108.13K
MARIANI PETER J
1 Feb 2023
EVP & Chief Financial Officer
Sold after exercise
14,550
$9.36
$136.19K
MARIANI PETER J
31 Jan 2023
EVP & Chief Financial Officer
Sold after exercise
14,320
$9.55
$136.76K
MARIANI PETER J
30 Jan 2023
EVP & Chief Financial Officer
Sold after exercise
14,111
$9.69
$136.74K
MARIANI PETER J
27 Jan 2023
EVP & Chief Financial Officer
Sold after exercise
20,940
$10.16
$212.75K
MARIANI PETER J
26 Jan 2023
EVP & Chief Financial Officer
Sold after exercise
20,939
$9.90
$207.30K
MARIANI PETER J
25 Jan 2023
EVP & Chief Financial Officer
Sold after exercise
20,939
$10.23
$214.21K
MARIANI PETER J
30 Oct 2020
Chief Financial Officer
Sold after exercise
1,745
$12.41
$21.66K
MARIANI PETER J
30 Oct 2020
Chief Financial Officer
Sold after exercise
12,854
$12.41
$159.52K
MARIANI PETER J
30 Oct 2020
Chief Financial Officer
Sold after exercise
1,084
$12.41
$13.45K
MARIANI PETER J
30 Oct 2020
Chief Financial Officer
Sold after exercise
60,000
$12.41
$744.72K
Showing 250 of 255 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 478
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 48
Sales at will 93
Transactions with no price 0
Shares from compensation/vesting 5,060,938
Sales filed before the plan box existed 57
History held since 13 Oct 2016